Effect of tumor gangliosides on tyrosine phosphorylation of p125FAK in platelet adhesion to collagen

Introduction

Tumor metastasis occurs through a multistep process (1). The interaction of circulating tumor cells that have detached from the primary tumor with structures of the tissue microvasculature is a crucial step preceding the invasion of the target organ. The specific events determining tumor cell interactions with endothelial cells during hematogenous metastasis are well defined (2); the role of other cell types such as platelets in this process, however, remains unclear.

Gangliosides, sialic acid-containing glycosphingolipids found in all eukaryotic cell membranes, play a role in cell-cell interaction, as well as in cell growth and proliferation (3). Gangliosides interact with a number of cell surface receptors (4–8) including integrin receptors (3,9). Neuroblastoma, an invasive, aggressive malignancy seen in children, is metastatic in 80% of patients at the time of presentation. Gangliosides are shed from the membrane of neuroblastoma cells into the extracellular milieu in large quantities. Gangliosides also affect platelet function. Gangliosides isolated from neuroblastoma tumor cells enhance platelet aggregation and activation and also promote platelet adhesion to extracellular matrix collagen (9–11). These effects are mediated through the integrin collagen receptor α2β1. Gangliosides shed from the tumor may therefore represent a paracrine factor which, by virtue of its platelet activating activity, promotes metastasis.

Since gangliosides modify signals from receptor tyrosine kinases (12), they interact with integrins that signal via the tyrosine kinase mechanism (13) and regulate integrin-dependent cell adhesion and spreading by affecting α5β1 signaling (14). One protein, focal adhesion kinase, p125FAK (FAK) localizes to focal plaques following cell adhesion to extracellular matrix (15). Its catalytic activity increases following cell adhesion to collagen (16). We speculated that tumor gangliosides might also modify the p125FAK signals generated by integrin in platelets. The present studies were undertaken to examine the effects of neuroblastoma tumor gangliosides (NBTGs) on α2β1-mediated p125FAK signaling in platelets.

Materials and methods

Monoclonal antibodies

Murine anti-human monoclonal antibodies against p125FAK and phosphotyrosine residues, and goat anti-murine horseradish peroxidase-conjugated antibody used for immunoblotting were purchased from Transduction Laboratories (San Diego, CA, USA). For immunoprecipitation of p125FAK, murine anti-human monoclonal antibody was purchased from Upstate Biotechnology (Lake Placid, NY, USA).

Extraction and purification of tumor gangliosides

Total gangliosides were isolated from the neuroblastoma tumor cell line LAN-5 cells as previously described (17). Total lipids were extracted twice with 10 volumes of chloroform-methanol (1:1); the extracts were then combined and dried under a stream of N2, re-dissolved in a small volume of chloroform-methanol (1:1) and stored overnight at −20°C. Insoluble glycoproteins were removed by centrifugation (1,000 × g, 4°C) and the supernatant was dried under a stream of N2. The gangliosides were isolated by partitioning the dried total lipid extract in di-isopropyl ether/1-butanol/water (6:4:5, v/v) (4), followed by Sephadex G-50 gel exclusion chromatography to remove traces of salts and other low molecular weight contaminants and further purified by normal phase high pressure liquid chromatography. The GD2 (disialoganglioside) fraction was collected, lyophilized and re-purified by gel exclusion chromatography to remove salts. Gangliosides were quantified as nmol lipid bound sialic acid (LBSA) as previously described (18), separated by high performance thin layer chromatography (HPTLC) and visualized as purple bands following staining with resorcinol reagent (5).

Platelet isolation

Platelet donors abstained from all medications for a minimum of 7 days, fasted overnight and provided written, informed consent. Platelets were isolated from donors according to the methods previously described (11). In brief, blood was drawn into tubes containing acid-citrate dextrose-A to which 35 U/ml preservative-free heparin was added. Platelet-rich plasma was isolated by centrifugation (3,000 × g, 15 min at 22°C) and then passed over Sepharose 2B (Amersham, Uppsala, Sweden) in modified Tyrode’s buffer (MTB) in the absence of Ca2+ or Mg2+.

Platelet adhesion assay

Platelet adhesion was determined as previously described (17). Collagen was diluted with isotonic glucose (pH 2.7–2.9) to a concentration of 40 μg/ml. One hundred microliters of this suspension was used to coat the wells of a polystyrene microtiter plate (Falcon 3915, Becton-Dickinson) overnight at 22°C. The wells were aspirated and blocked with 100 μl of 0.5% BSA solution for 1 h at 22°C and then washed 3 times with MTB. Control wells were coated with BSA alone. Gel-filtered platelets were adjusted to 105/μl in MTB without MgC12 and incubated with purified tumor gangliosides at the specified concentration for 30 min at 37°C with gentle mixing. The platelets were washed once to remove unbound gangliosides and resuspended in MTB with 2.56 mM MgC12, and 100 μl of the final platelet suspension was added to the wells and incubated for 1 h at 37°C with gentle mixing. The wells were vigorously washed 5 times with 100 μl MTB to remove non-adherent platelets and loose aggregates. The number of adherent platelets was determined using the BCA assay (Pierce, Rockford, IL, USA) as previously described (17). Absorbance was measured at 570 nm (OD570) with a microtiter plate reader (BioTek Instruments, Winooski, VT, USA). In each experiment, a standard curve of OD570 and platelet number was constructed by adding platelets (103–106 per well) to collagen-coated, BSA-blocked wells as described above. An average OD570 value was calculated from triplicate wells over the range of platelet concentrations and related to direct phase-contrast microscopy counts by linear regression analysis. In all experiments, a direct correlation was observed between measured OD570 and platelet number (r2>0.95). OD570 values of 0.1, 0.2, 0.3 and 0.4 represent platelet numbers of 1.76×103, 1.57×104, 1.39×105 and 1.26×106, respectively.

Effects of NBTGs on protein tyrosine phosphorylation of platelets adherent to collagen

The effects of NBTGs on protein tyrosine phosphorylation signaling through α2β1 integrin were examined in platelets adherent to immobilized collagen. Collagen was diluted in isotonic glucose (pH 2.7–2.9) to a concentration of 100 μg/ml and 600 μl of this suspension was used to coat the surface of 6-well plates (Falcon 1143, Becton-Dickinson, Oxnard, CA, USA) overnight at 22°C. Wells were blocked with 0.1% BSA prior to adding platelets. Gel-filtered platelets (105/ml) were incubated with 1 μmol NBTGs or GD2 dissolved in MTB with 2.56 mM MgCl2 and 100 mM Na3VO4 at 37°C for 30 min. Then, 1.2 ml of platelet suspension was added to the wells and incubated for 1 h at 37°C with gentle mixing. Non-adherent platelets were removed by aspiration, concentrated by centrifugation and lysed with ice cold lysis buffer (50 mM Tris, pH 8.0, 2.0 mM EDTA, 0.15 M NaCl, 1% Triton X-100, 200 mM Na3VO4, 1 mM PMSF, 1 μg/ml aprotinin and 1 μg/ml leupeptin) at 4°C. Residual adherent platelets were lysed directly in the wells.

Immunoprecipitation

Protein lysates were incubated with washed Pansorbin cells (Calbiochem, La Jolla, CA, USA) for 30 min at 4°C with mixing. The sample was clarified (12,000 × g for 15 min at 4°C) and the protein recovered, then incubated overnight at 4°C with monoclonal antibody against p125FAK (2 mg/ml). To precipitate the p125FAK antibody complex, Protein G Plus-Agarose beads were added and the lysate was incubated for 4 h at 4°C. The complex was then recovered and washed thrice with Triton X-100 lysis buffer. Immune complexes were boiled in equal volume of 2X loading buffer for 2 min and the supernatant was recovered and immunoblotted.

Immunoblotting

Lysates were clarified by centrifugation (12,000 × g for 15 min at 4°C) and the supernatant was collected. Protein content in each sample was determined using the BCA assay. Western blotting of platelet lysates was performed with equal amounts of protein mixed with 1:1 vol of 2X loading buffer, then boiled at 100°C for 2 min and analyzed by 6 or 7.5% SDS-polyacrylamide gel electrophoresis. Proteins were transferred to a nitrocellulose membrane (Amersham) using a wet transfer module (Bio-Rad Laboratories, Hercules, CA, USA). Membranes were blocked with buffer A (1% BSA or 5% non-fat milk, 50 mM Tris, 0.1% Tween-20, 100 mM NaCl, pH 7.5) for 1 h. The immunoblots were probed with anti-phosphotyrosine monoclonal antibody (PY-20) or anti-p125FAK monoclonal antibody (1/1,000) in buffer A for 1 h, washed and then incubated with HRP-conjugated secondary antibody (1/1,000) for 1 h. Proteins were visualized by enhanced chemiluminescence (ECL) and exposed to Hyperfilm ECL (Amersham).

Results

Ganglioside compositions in LAN-5 neuroblastoma cell lines

The chromatographic profile of the LAN-5 cell line gangliosides is shown in Fig. 1. Human brain gangliosides (gift from Dr Zhengmei Zhu) were used as a standard. The predominance of GD2 is evident in the cell line, the other major composition is GM2, fewer compositions include GD3, GT1b.

Figure 1 Chromatographic profile of gangliosides from LAN-5 cell lines. S, standard gangliosides; lane 1, LAN-5.

Neuroblastoma tumor gangliosides enhance α2β1 integrin-mediated platelet adhesion to collagen

In Fig. 2, platelets pre-incubated with 1 μmol total NBTG or the major individual ganglioside GD2 were more adherent to immobilized collagen (OD570 0.43±0.12, 0.39±0.13) compared to platelets pre-incubated with MTB (0.14±0.06, P<0.001). Adhesion was maximal by 30 min, and no further increase was observed with incubation duration up to 120 min (not shown). No effect of MTB on platelet adhesion to collagen was observed. α2β1 integrin is the major collagen receptor on platelets, adhesion experiments were performed with anti-α2 monoclonal antibody to block the α2β1 receptor. In Fig. 3 adhesion of NBTG-pre-incubated platelets was reduced to control levels by F-17 anti-α2 antibody (OD570 0.11±0.05 vs. 0.13±0.06 P>0.05).

Figure 2 Effect of NBTGs on platelet adhesion to collagen. Gel-filtered platelets were pre-incubated with 1 μM NBTGs for 30 min at 37°C with gentle mixing. Unbound gangliosides were removed by centrifugation, and the final platelet product was resuspended to 105/μl in MTB with 2.56 mM MgCl2. The platelet suspension (100 μl) was added to collagen-coated (4 μg/well), BSA-blocked wells and allowed to incubate for 1 h at 37°C with gentle mixing. Following removal of the non-adherent platelets, the residual adherent platelet number was estimated using the BCA assay. The mean and standard deviation of 4 experiments performed in 6 replicates is shown.

Figure 3 Effect of anti-α2 antibody on NBTG-enhanced platelet adhesion to collagen. Gel-filtered platelets were pre-incubated with 1 μM NBTGs for 30 min at 37°C with gentle mixing. Unbound gangliosides were removed by centrifugation, and the final platelet product was resuspended to 105/μl in MTB containing 10 μg/ml F-17 anti-α2 antibody and 2.56 mM MgCl2, then incubated for 30 min at 37°C; excess antibody was not washed away. The platelet suspension (100 μl) was added to collagen-coated (4 μg/well), BSA-blocked wells and allowed to incubate for 1 h at 37°C with gentle mixing. Following removal of the non-adherent platelets, the residual adherent platelet number was estimated using the BCA assay. The mean and standard deviation of 4 experiments performed in 6 replicates is shown.

Effects of neuroblastoma tumor gangliosides on tyrosine phosphorylation of platelet adhesion to collagen

We examined the effects of NBTGs on phosphotyrosine signaling following platelet adhesion to immobilized collagen (Fig. 4). Adherent platelets were immunoprecipitated with anti-p125FAK antibody, then examined with an antiphosphotyrosine (Fig. 4A) or anti-p125FAK (Fig. 4B) antibody. The phosphotyrosine intensity of the p125FAK band (Fig. 4A) in platelets pre-incubated with NBTGs (lane 1) or GD2 (lane 2) was increased compared to MTB buffer-pre-incubated adherent platelets (lane 3). Total p125FAK protein content in each sample is comparable (Fig. 4B) and is not affected by gangliosides.

Figure 4 Effect of NBTGs and GD2 on tyrosine phosphorylation of platelets adherent to immobilized collagen. Gel-filtered platelets were pre-incubated with 1 μM NBTGs and GD2 (lanes 1 and 2) for 30 min at 37°C or with MTB buffer (lane 3). The platelet suspension was added to collagen-coated 0.1% BSA-blocked wells and allowed to incubate for 1 h at 37°C with gentle mixing. Non-adherent platelets were removed, adherent platelets were lysed directly in the plates on ice using lysis buffer. An equal amount of protein was analyzed by SDS polyacrylamide gel electrophoresis and immunoblotting with anti-phosphotyrosine (A) and anti-p125FAK antibodies (B).

The effects of the gangliosides on tyrosine phosphorylation were explored in platelets adherent to immobilized collagen and in the non-adherent platelets (Fig. 5). Pre-incubation of platelets with 1 μM NBTGs (lane 1) resulted in marked increases in the phosphotyrosine content of p125FAK (Fig. 5A) in the adherent platelets compared to the MTB-pre-incubated adherent platelets (lane 2); a similar, but less striking, effect of NBTGs on non-adherent platelets (lane 3) was observed, compared to MTB buffer-pre-incubated non-adherent platelets (lane 4). Total p125FAK protein content in each sample is comparable (Fig. 5B) and is not affected by the gangliosides.

Figure 5 Effects of anti-α2 antibody on tyrosine phosphotyrosine content of NBTG-treated platelets adherent to immobilized collagen. Gel-filtered platelets were pre-incubated with 1 μM NBTGs (lane 1), or with 1 μM NBTGs plus 10 μg/ml F-17 anti-α2 antibody (lane 2) or with MTB buffer (lane 3), or with MTB buffer plus 10 μg/ml F-17 anti-α2 antibody (lane 4) for 30 min at 37°C. The platelet suspensions were added to collagen-coated 0.1% BSA-blocked wells and allowed to incubate for 1 h at 37°C with gentle mixing. Non-adherent platelets were removed, adherent platelets were lysed directly in the plates on ice using lysis buffer. The remainder of the experiment was performed as described in Fig. 4.

NBTGs enhance the phosphotyrosine signaling through α2β1 integrin following platelet adhesion to collagen

As we have shown NBTGs enhance α2β1 integrin-mediated platelet adhesion to collagen, we further assessed this receptor’s role in the phosphotyrosine signaling of NBTG-enhanced platelet adhesion to collagen by performing experiments in the presence or absence of an α2-blocking antibody F-17. In Fig. 6, F-17 anti-α2 antibody decreased protein tyrosinephosphorylation of NBTG-incubated platelets adherent to collagen (Fig. 6A). Adherent platelets pre-incubated with NBTGs and F-17 anti-α2 antibody (lane 2) had significantly reduced phosphorylation of p125FAK protein compared to adherent platelets pre-incubated only with NBTGs (lane 1). Total p125FAK protein content in each sample is comparable (Fig. 6B) and is not affected by the gangliosides.

Figure 6 Effects of NBTGs on tyrosine phosphorylation of platelets adherent and non-adherent immobilized to collagen. Gel-filtered platelets were pre-incubated with 1 μM NBTGs (lanes 1 and 2) or with MTB buffer (lanes 3 and 4) for 30 min at 37°C. The platelet suspension was added to collagen-coated 0.1% BSA-blocked wells and allowed to incubate for 1 h at 37°C with gentle mixing. Non-adherent platelets (lanes 3 and 4) were removed and sedimented then lysed and the protein isolated. Adherent platelets (lanes 1 and 2) were lysed directly in the plates on ice using lysis buffer. The remainder of the experiment was performed as described in Fig. 4.

Discussion

Both clinical and experimental evidence point to a role of platelets in the spread of cancer. Patients with metastatic disease reveal increased platelet counts and significantly elevated numbers of activated platelets (19). Depending on the type of tumor, various aspects of cancer progression may be affected by platelets, including tumor cell proliferation (20), tumor angiogenesis (21), vessel stability within tumors (22) or immune evasion (23,24). Integrins, a widely expressed family of transmembrane adhesion receptors, represent a central determinant for physiological platelet function. GPIIb/IIIa is involved in both cell-cell adhesion and thrombus formation at the vascular wall, establishing it as a therapeutic target in vascular diseases (25). Pharmacological inhibition of GPIIb/IIIa has been demonstrated to reduce tumor cell metastasis, although the underlying mechanisms remain elusive (26). Similarly to GPIIb/IIIa results (14), Shield et al(27) reported that enhanced expression of α2β1 integrin may influence spheroid disaggregation and proteolysis responsible for the peritoneal dissemination of ovarian carcinoma. Their findings raise the possibility that α2β1 integrin may represent a valuable therapeutic target in the suppression of intra-peritoneal spread associated with the progression of ovarian cancer. The expression of α2β1-integrin in peritoneal lesions was significantly increased compared with its expression in the primary lesion in the same individual. Peritoneal implantation of gastric carcinoma might be closely associated with α2β1-integrin (28). Increasing evidence has implicated gangliosides, sialic acid-containing cell surface glycosphingolipids, in the biological and clinical behavior of many types of human tumor. Gangliosides are overexpressed and actively shed by tumor cells; they can bind to normal cells in the tumor microenvironment and have a number of biological properties that could conceivably alter tumor-host interactions to influence the survival of the malignant cells that carry these molecules. Collectively, these diverse observations reported in the literature have prompted us to investigate the modulation of platelet signaling by tumor gangliosides.

Gangliosides increase platelet aggregation, secretion (11) and adhesion (10). These activities are mediated through the collagen-binding integrin α2β1(9). NBTGs increase α2β1-dependent platelet activation and adhesion (17). In this study, we also showed that NBTGs increase α2β1-dependent platelet adhesion to immobilized collagen (Figs. 2 and 3) and increase intracellular phosphotyrosine signals following integrin ligation by immobilized ligand (Figs. 4–6).

Integrins, a widely expressed family of transmembrane adhesion receptors, represent a central determinant for physiological platelet function. A unique feature of integrins is the ability to regulate adhesive competence. The ability to bind ligand may be due to clustering into focal adhesions (29–31). An early event during integrin signaling is tyrosine phosphorylation. Several protein tyrosine kinases have been implicated in integrin signaling events by virtue of their integrin dependent activation or their localization into focal contacts. p125FAK appears to play a central role in integrin-mediated signal transduction. This kinase is tyrosine phosphorylated and its tyrosine kinase activity is enhanced upon integrin-mediated engagement (32). Blood platelets contain high levels of tyrosine kinases (33,34) and activation by various agonists including collagen leads to tyrosine phosphorylation of many proteins (16,35–37). Tyrosine phosphorylation of p125FAK has been demonstrated during thrombin or collagen-induced aggregation mediated by the αIIbβ3 integrin (38). Platelet activation leads to the upregulation of tyrosine kinases, including FAK (39). FAK, a 125-kDa cytosolic non-receptor tyrosine kinase, is associated with focal adhesion plaques of adherent cells such as fibroblasts and platelets (40). FAK is of particular interest, as it is considered a key intermediary of signaling through integrins (31,41). The present study addresses the role of the collagen receptor α2β1 in the regulation of FAK. Collagen activates FAK, as indicated by its tyrosine phosphorylation state. The antibodies against the α2 integrin, which prevent adhesion to collagen, block FAK activation, the results demonstrate that α2β1 occupancy by collagen fibers regulate FAK. Our data suggest that α2β1 ligation by immobilized ligand is capable of inducing phosphotyrosine signals.

Neuroblastoma, a neoplasm originating from neural crest cells, is the most common extracranial solid tumor of childhood. Gangliosides shed from neuroblastoma tumors are capable of enhancing platelet secretion, aggregation (9,10), adhesion (42) and promote tumor cell migration and invasion (43). Our data show that neuroblastoma tumor gangliosides enhance integrin α2β1 mediated platelet adhesion to type I collagen and the phosphorylation of pFAK125 provide an argument for a role of tumor gangliosides in metastasis. Jabbar et al(44) presented a 9-step model to explain the role of gangliosides in metastasis: gangliosides shed from tumor cells incorporate into the platelet membrane, then induce α2β1 integrin clustering, clustered integrins interact with soluble collagen or with extracellular matrix collagen, intracellular signals (such as activation of focal adhesion kinase) are maximally generated when integrins are clustered and ligand is bound. These signals lead to cell-platelet adhesion, secretion, aggregation and promote tumor metastasis. Our results provide indirect evidence to confirm the model.

Acknowledgements

This study was supported by the grant S2011010004349 from the Natural Science Foundation of Guangdong Province and the Medical Key Subject of Health, Population and Family Planning Commission of Shenzhen Municipality (2011026).

References